Ogden Christopher
- SEC CIK
- 0001914523
In the past year, 2 open-market sale filings worth $129.0K and no purchases.
Current role at each company
- CTMX CytomX Therapeutics, Inc.Chief Financial Officeras of Jun 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $129.0K
- 2 filings
- Net
- −$129.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ogden Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Ogden ChristopherChief Financial Officer | SSale | −1.62K | $3.05 | −$4.95K | −0.5%295.3K after | |
| Mar 19, 2026 (view filing) | Mar 17 | 2 days | Ogden ChristopherChief Financial Officer | SSale | −19.3K | $6.42 | −$124.1K | −6.1%296.9K after | |
| Jun 17, 2025 (view filing) | Jun 13-16 | 4 days | Ogden ChristopherChief Financial Officer | SSale | −12.3K | $2.72 | −$33.4K | −5.1%226.3K after | 2 lots |
| Mar 20, 2025 (view filing) | Mar 18 | 2 days | Ogden ChristopherChief Financial Officer | SSale | −8.55K | $0.60 | −$5.13K | −4.1%201.0K after | |
| Aug 22, 2024 (view filing) | Aug 20 | 2 days | Ogden ChristopherChief Financial Officer | SSale | −1.98K | $1.23 | −$2.44K | −1.8%108.1K after | |
| Mar 21, 2024 (view filing) | Mar 19 | 2 days | Ogden ChristopherSVP, Finance and Accounting | SSale | −2.97K | $2.09 | −$6.21K | −3.4%85.7K after | |
| Dec 22, 2023 (view filing) | Dec 20 | 2 days | Ogden ChristopherSVP, Finance and Accounting | SSale | −1.99K | $1.38 | −$2.75K | −3.9%48.7K after | |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Ogden ChristopherSVP, Finance and Accounting | SSale | −516 | $1.98 | −$1.02K | −1.3%37.8K after |